LFCR Q4 2021 Earnings — Lifecore Biomedical, Inc. Revenue & Financial Results | Market Cap Arena

LFCRLifecore Biomedical, Inc.

$267M

Q4 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$140M-10.4% YoY

Gross Profit

$25M17.7% margin

Operating Income

$1M0.9% margin

Net Income

-$3M-2.0% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+212.9%

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

-$8M

Stock-Based Comp.

$776,000

Balance Sheet

Total Assets

$503M

Total Liabilities

$300M

Stockholders' Equity

$203M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$140M	$156M	-10.4%
Gross Profit	$25M	$24M	+3.0%
Operating Income	$1M	-$13M	+109.4%
Net Income	-$3M	-$15M	+81.1%